Prof. David Tougeron provides the GI cancer highlights from ESMO 2020. Watch the video and download the slides.
Prof. David Tougeron provides the GI cancer highlights from ESMO 2020. Watch the video and download the slides.
Dr David Tougeron is a professor of gastroenterology at Poitiers University Hospital, France. His clinical interests focus on gastrointestinal cancers, in particular, colorectal cancer. Dr Tougeron has participated in more than 40 clinical trials in digestive oncology and has co-authored more than 50 articles, editorials and book chapters. After a Ph.D. in immune response in colorectal cancer, Dr Tougeron completed a postdoctoral position at the Mayo Clinic, U.S., in colorectal cancer chemosensitivity. His research is currently focussing on colorectal cancer, particularly colorectal cancer with microsatellite instability and predictive biomarkers of response to targeted therapies. He presently holds professional positions in different organisations, notably the Fédération Francophone de Cancérologie Digestive (FFCD).
Amgen, AstraZeneca, Bayer, BMS, Merck Serono, MSD, Pierre Fabre, Roche, Sanofi and Servier.
Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer
Αναλύσεις από καταξιωμένους ειδικούς ιατρούς. Πλοηγηθείτε στις καρτέλες για να επιλέξετε ένα επεισόδιο podcast
How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC?
Understanding the role of molecular subtypes in guiding treatment selection
Uznani eksperci dzielą się swoimi spostrzeżeniami. Kliknij na odpowiednią zakładkę, aby wybrać odcinek podcastu.